Elekta AB (publ) (LON:0O5H)

Market Cap	1.72B -6.0%
Revenue (ttm)	1.41B -0.9%
Net Income	23.41M -70.9%
EPS	0.06 -71.0%
Shares Out	n/a
PE Ratio	73.43
Forward PE	15.13
Dividend	0.19 (0.34%)
Ex-Dividend Date	Sep 5, 2025

Volume	21,093
Average Volume	489,542
Open	55.50
Previous Close	55.35
Day's Range	54.35 - 55.30
52-Week Range	42.20 - 67.20
Beta	1.10
RSI	33.89
Earnings Date	Mar 5, 2026

About Elekta AB

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers linear accelerator and radiation therapy products comprising Elekta Unity for anatomy-specific MR imaging; Elekta Evo that delivers offline and online adaptive radiation therapy; Elekta Versa HD, a brain metastases solution; Elekta Harmony; and Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs, as wel...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1972
• Employees: 4,484
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0O5H

Financial Performance

In fiscal year 2025, Elekta AB's revenue was 18.02 billion, a decrease of -0.57% compared to the previous year's 18.12 billion. Earnings were 237.00 million, a decrease of -81.80%.

Financial numbers in SEK